Medtronic has issued a voluntary recall of its MiniMed insulin pumps due to potentially shortened battery life, which could lead to health risks like hyperglycemia or diabetic ketoacidosis. The FDA classified the recall as the most serious type, with a reasonable chance of serious injury or death. The company advises users to monitor battery status, replace batteries when the “Low Battery Pump” alarm sounds, carry extra batteries, and have a backup therapy. Medtronic has received reports of hyperglycemia and ketoacidosis. Users experiencing a significant decrease in battery life should contact the company to determine if a replacement pump is needed.
Source link
Medtronic issues voluntary recall of MiniMed insulin pumps
